Utility of Some Novel Biomarkers of Patients With Chronic Heart Failure

Not Applicable

Recruiting

• Conditions: Heart Failure
• Interventions: Diagnostic Test: New york Heart Association Class II-IV; Diagnostic Test: New york Heart Association Class I

• Registration Number: NCT03772275
• Lead Sponsor: Sherief Abd-Elsalam

Brief Summary

Clinical and Economic study of some new biomarkers in chronic heart failure.

Detailed Description

The study aimed at evaluation of the clinical and economic value of some new biomarkers in chronic heart failure.

Study Timeline

• Study Start: 2018-10-01
• Status Verified: 2018-12
• Study First Submitted: 2018-12-07
• Study First Submitted QC: 2018-12-08
• Last Update Submitted: 2018-12-08
• Study First Posted: 2018-12-11
• Last Update Posted: 2018-12-11
• Primary Completion: 2026-10
• Study Completion: 2027-10

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• NYHA-Class II-IV

Exclusion Criteria

• Liver or renal dysfunction. --DM

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
New york Heart Association Class II-IV	New york Heart Association Class II-IV	New york Heart Association Class II-IV heart failure
New york Heart Association Class I	New york Heart Association Class I	New york Heart Association Class I with no heart failure

Primary Outcome Measures

Name	Time	Method
Number of participants with elevated markers (IL17)	6 months	Number of participants with elevated markers (IL17)

Trial Locations

Locations (1)

Sherief Abd-Elsalam; 🇪🇬 Tanta, Elgharbia, Egypt